Nicholas M. Boulis

Angiotropic large cell lymphoma with imaging characteristics of CNS vasculitis.

Neuronal survival following remote adenovirus gene delivery.

Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery.

Molecular biology and gene therapy in the treatment of chronic pain.

Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery.

Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.

Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro.

A preliminary study of transient confusional states following bilateral subthalamic stimulation for Parkinson's disease.

Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.

A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting.

Neuroprotective adeno-associated virus Bcl-xL gene transfer in models of motor neuron disease.

Gene-based treatment of motor neuron diseases.

Thoracoscopically guided transaxillary resection of adjoining intercostal plexiform neurofibromas: review of mosaicism in neurofibromatosis: technical note.

X-Linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system.

Neuronal affinity of a C7C loop peptide identified through phage display.

Viral clostridial light chain gene-based control of penicillin-induced neocortical seizures.

Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.

Molecular mechanisms of pain: a basis for chronic pain and therapeutic approaches based on the cell and the gene.

Motor neuron inhibition-based gene therapy for spasticity.

A means for targeting therapeutics to peripheral nervous system neurons with axonal damage.

An invasion of the atlas.

Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief.

Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra.

Intrathecal opioids for control of chronic low back pain during deep brain stimulation procedures.

Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation.

Clinical problem solving: family matters.

Clinical problem solving: seize the day.

Methods of scalp revision for deep brain stimulator hardware: case report.

Clinical problem solving: lightning never strikes twice?

Clinical problem-solving: island intruder.

Ribonucleic acid interference: the relevance of molecular targeting and therapeutics to neurosurgical practice.

Surgery for movement disorders.

Clinical problem-solving: brachial plexus closed injury and reconstruction.

Fusion of the tetanus toxin C fragment binding domain and Bcl-xL for protection of peripheral nerve neurons.

Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.

Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer.

Modern treatment of cerebral metastases: Integrated Medical Learning(SM) at CNS 2007.

A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis.

Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform.

Invited review: festschrift edition of neurosurgery peripheral nervous system as a conduit for delivering therapies for diabetic neuropathy, amyotrophic lateral sclerosis, and nerve regeneration.

Clipping versus coiling for ruptured intracranial aneurysms: integrated medical learning at CNS 2007.

Viral vector-mediated gene transfer for CNS disease.

To glue or not to glue? That is the question!!!

Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs.

Clinical problem-solving: aneurysm or spinal arteriovenous fistula-bait and switch.

Clinical problem solving: monster on the hook--case problems in neurosurgery.

Stem cell technology for the study and treatment of motor neuron diseases.

Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.

Platform and cannula design improvements for spinal cord therapeutics delivery.

Treatment of Harlequin syndrome by costotransversectomy and sympathectomy: case report.

Assessment of hippocampal adeno-associated viral vector gene delivery via frameless stereotaxis in a nonhuman primate.

Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.

Gene therapy for amyotrophic lateral sclerosis.

A patient revoking consent during awake craniotomy: an ethical challenge.

Translational stem cell therapy for amyotrophic lateral sclerosis.

Characterization of a murine model of SMA.

Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.

Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.

Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.

Stem cell therapy for the spinal cord.

Update on gene and stem cell therapy approaches for spinal muscular atrophy.

An overview of domestic and international clinical trials for delivery of cellular therapies to the spinal cord.